Skip to content
Agentic OS
Menu

Intelligence / Healthtech / New Clinical Trials / STORM Therapeutics LTD

Clinicaltrial registered30 Oct 2026

STORM Therapeutics LTD

30 Oct 2026: Trial registered · Expanded Access Program to Provide STC-15 to Patients With Selected Advanced Cancer. Recorded in the ClinicalTrials.gov (US National Library of Medicine).

View the source record

Posted
30 Oct 2026
Title
Expanded Access Program to Provide STC-15 to Patients With Selected Advanced Cancer
Conditions
Cancer
Study Type
Expanded Access
Status
Available
Reference
NCT07906093
What this signal means

A new trial needs sites, patients, data capture, monitoring and regulatory partners for years.

  1. United States leads with 192 of 777, then China (171).
  2. 777 added in the 30 days to 18 Nov 2026.
Reach them with AOS

Find the decision makers at STORM Therapeutics LTD

AOS maps the buying committee, finds verified work emails and drafts outreach that cites this clinical signal, for your approval.

Start free

Source: ClinicalTrials.gov (US National Library of Medicine), data to 18 Nov 2026. Trials first posted in the window whose lead sponsor is a company, worldwide. Device and diagnostic studies usually have no phase. AOS shows what the public record says; it does not verify or endorse the company.